An upregulation of MIF has been reported to be detrimental in several neurodegenerative diseases such as Alzheimer’s disease (AD), mild cognitive impairment, Parkinson ́s disease and multiple sclerosis (MS) [16–20]. Here, MIF is linked to myeloid sarcoma.